Radius Health Inc. (RDUS)

27.47
0.41 1.50
NASDAQ : Health Technology
Prev Close 27.05
Open 27.17
Day Low/High 27.12 / 27.84
52 Wk Low/High 12.81 / 29.97
Volume 225.67K
Avg Volume 541.40K
Exchange NASDAQ
Shares Outstanding 46.12M
Market Cap 1.20B
EPS -4.90
P/E Ratio N/A
Div & Yield N.A. (N.A)
5 Stocks Insiders Love Right Now

5 Stocks Insiders Love Right Now

Insiders at these companies have been scooping up shares of their own stock lately.

Looking for the Next Receptos Is Plain Stupid Right Now

These stocks will be up so high today, that many fans will say "no thanks."

Radius Health Announces Multiple Presentations At The American Society For Bone And Mineral Research 2015 Annual Meeting

Radius Health Announces Multiple Presentations At The American Society For Bone And Mineral Research 2015 Annual Meeting

Meeting to Include an Oral Presentation of the Results of the ACTIVExtend Trial in the Plenary Session

What Will It Take to Boost Markets Back in the Green? Cramer Explains

What Will It Take to Boost Markets Back in the Green? Cramer Explains

Halfway through an ugly week, the question on investors' minds is, what needs to happen to get the market headed in the right direction? Jim Cramer has a long checklist.

Jim Cramer: Expect Decline in Apple but Don't Trade It

Jim Cramer: Expect Decline in Apple but Don't Trade It

Jim Cramer answers viewers' Twitter (TWTR) questions from the floor of the New York Stock Exchange. He weighs in on Apple (AAPL), Alcoa (AA), Walgreens (WBA), Disney (DIS) and more.

Blame the E.U.; Don't Ignore the Good News; ... But Stay Skeptical: Jim Cramer's Best Blogs

Blame the E.U.; Don't Ignore the Good News; ... But Stay Skeptical: Jim Cramer's Best Blogs

Catch up on Jim Cramer's ideas from this past week as he discusses how the E.U. abetted the Greek crisis, good news we're ignoring, and whether it's time to bargain-hunt.

Cramer Is Flying Southwest, Won't Recommend Sarepta Therapeutics

Cramer Is Flying Southwest, Won't Recommend Sarepta Therapeutics

Cramer tells TheStreet's Brittany Umar he is working on a surprise piece that will 'blow the doors off' McDonald's.

Cramer Worried About Airline Overcapacity, Hints at Surprise McDonald's Piece

Cramer Worried About Airline Overcapacity, Hints at Surprise McDonald's Piece

Jim Cramer likes Soutwest (LUV), isn't a fan of Sarepta Therapeutics (SRPT) and will soon have a 'surprise' piece on McDonald's (MCD).

Jim Cramer's 'Mad Money' Recap: Here Are the Stocks You Could've Picked Off Cheap

Jim Cramer's 'Mad Money' Recap: Here Are the Stocks You Could've Picked Off Cheap

A quarter of the market bottomed today, which means stocks in biotech, among other areas, were there for the taking, Cramer says.

Greece's Alexis Tsipras Made 5 Mistakes in Negotiations With Europe

And now he's in electioneering mode at its worst.

This Is Still a Time for Selling, Not Buying in the Stock Market

I wonder why skepticism disappears so quickly these days.

Jim Cramer's Top Takeaways: Home Depot, Lowe's, Nike, G-III, Receptos

Jim Cramer's Top Takeaways: Home Depot, Lowe's, Nike, G-III, Receptos

Cramer says Home Depot and Lowe's are how you play the resurgence in home buying while Nike reminds us why we invest in the first place.

Jim Cramer's 'Mad Money' Recap: What Were Those Delusional Bulls Thinking?

Jim Cramer's 'Mad Money' Recap: What Were Those Delusional Bulls Thinking?

The bulls got complacent and they paid the price Monday, Cramer says.

Jim Cramer's Top Takeaways: UnitedHealth, Ambarella, Radius Health

Jim Cramer's Top Takeaways: UnitedHealth, Ambarella, Radius Health

Cramer says UnitedHealth is a best of breed health insurer and Ambarella is more than just GoPro.

Jim Cramer's 'Mad Money' Recap: Let the Good Stocks Shine

Jim Cramer's 'Mad Money' Recap: Let the Good Stocks Shine

Investors stopped worrying about Greece and chose from a menu of great stocks with long-term growth potential, Cramer says.

Jim Cramer's Top Takeaways: BioMarin, Radius Health, Allergan, Diageo, Wayfair

Jim Cramer's Top Takeaways: BioMarin, Radius Health, Allergan, Diageo, Wayfair

Cramer says BioMarin, Radius Health and Allergan are winners but stay away from Diageo.

Jim Cramer's 'Mad Money' Recap: Here's Why We Had a Rally Today

Jim Cramer's 'Mad Money' Recap: Here's Why We Had a Rally Today

The Federal Reserve statement, Greece, selling the dollar and investor confidence all had a hand, Cramer says.

Martha Stewart Surges on Deal Reports; Nasdaq Seals Record Close

Martha Stewart Surges on Deal Reports; Nasdaq Seals Record Close

Sequential Brands (SQBG) and Martha Stewart Living Omnimedia (MSO) rocketed higher by late afternoon Thursday.

Jim Cramer -- BioMarin and Radius Health Deserve Today's Big Rally

Jim Cramer -- BioMarin and Radius Health Deserve Today's Big Rally

TheStreet's Jim Cramer praised Radius Health and BioMarin for their treatments results, which prompted a slew of analyst price target increases.

Radius Health (RDUS) Stock Spikes on Positive Top-Line Trial Data

Radius Health (RDUS) Stock Spikes on Positive Top-Line Trial Data

Radius Health (RDUS) shares are up over 15% after the company reported positive results from its osteoperotic fracture treatment candidate trials.

AXON, REGN, BURL, FIVE: Jim Cramer's Views

AXON, REGN, BURL, FIVE: Jim Cramer's Views

Jim Cramer shares his views on the latest moves in biotech and retail. Account, Regeneron, Burlington Stores and Five Below are among the many stocks discussed here.

TheStreet Quant Rating: D- (Sell)